Start Codon

Up next in our series of exhibiting companies at our Innovation Showcase is Proxximos, a founder-generated company that has developed a proprietary WebApp and wearable solution to prevent harmful and costly infections spreading around hospitals and care homes. The bespoke wearables have been designed in collaboration with healthcare professionals for use by both staff and patients. The tracking solution is providing by a third-party hardware company. The WebApp enables health and care workers to find infected people precisely and quickly, hence enabling control measures to prevent further onward spread. This innovative solution is expected to have a significant impact for NHS trusts where 20% of bed capacity is tied up treating people who have acquired an infection during their stay. They anticipate benefits of 25% fewer patient deaths, 5% capacity increase, and 90% clinical time saved in comparison to manual contact tracing. Interested in learning more? Register to join us and hear from Proxximos' Co-Founder and CEO, Peter Whawell: https://rb.gy/qc7bfg #Healthcare #PandemicDefence #Innovation #DigitalHealth

Last week, we introduced you to our four presenting portfolio companies at this year's Innovation Showcase. In celebration of Start Codon's five-year anniversary, this year our presenting companies will also be joined by Adora Digital Health, Verinnogen, Cardiac-Tech Ltd, and Proxximos, who will be giving live demonstrations of their technology, giving you the chance to see their progress in action and meet with members of their team to find out more.   Kicking off our series of exhibiting companies, meet Verinnogen!   Verinnogen has developed a novel, contact-based surface profiling tool that will transform the way we interact with, understand, and measure physical objects such as subcutaneous tumours and other biological tissues.   Designed to address the problem of error-prone calliper measurements in pre-clinical cancer research, Verinnogen's moveable pin approach has already demonstrated a four-fold reduction in operator variability in vivo, a key drawback of calliper-based measurements, using their prototype device.   The 3D profiling technology has also been developed to integrate additional measurements, such as body condition scoring, surface temperature, and tissue elasticity.   To find out more about Verinnogen's innovative technology and speak with Dr Isaac Johnson, CEO, and Dr Mike Irvine, CTO at Verinnogen, register your interest here: https://rb.gy/qc7bfg   Stay tuned this week to learn more about the rest of our exhibiting companies!   #3Dprofiling #CancerResearch #MedicalDevice

Our fourth and final presenting portfolio company at our Innovation Showcase is Emm, the start-up whose mission is to empower individuals to change their quality of life by inherently understanding their health through technology and specialist knowledge.   Less than 2.5% of publicly funded research is dedicated solely to reproductive health, yet 1 in 3 women will suffer from a reproductive or gynaecological health problem.   Clinical baseline data is key for tracking reproductive health, but neither consumers nor clinicians have the tools to accurately measure this.   Founded by CEO, Jenny Button, Emm has built biometric technology to bring this data to the 1/3 of women with severe reproductive health symptoms. Their technology can monitor key metrics like volume, flow rate, cycle length and regularity to aid understanding of menstrual health.   To hear more about Emm's technology, or to meet with Jenny, please register your interest here: https://rb.gy/qc7bfg   #ReproductiveHealth #MenstrualHealthcare #WomensHealth #StartUp #Innovation

Our thanks to Venner Shipley for hosting our Meet the Experts START Programme event this week. Throughout the day, founders got to hear from experts on finance, legal, intellectual property, communications and commercialisation. In between sessions there was the chance to network with each other and our experts. A big Start Codon thank you to Venner Shipley, Zyme Communications Ltd, Taylor Wessing, PEM and Triple Chasm for supporting the day and to all the founders who came along and actively engaged in the sessions. #StartUps #Founders #Networking

Next up in our Innovation Showcase series, meet Indegra Therapeutics! Founded by Richard Hatley and Simon Macdonald in 2022, Indegra Therapeutics is an integrin-based drug discovery platform company with a radically different approach to unlock effective treatments for multiple diseases, including cancer and autoimmune diseases. Its technology allows degradation of aberrant extracellular and membrane bound proteins with novel bifunctional molecules. The extracellular proteome contains many disease targets which are largely untapped and Indegra’s mission is to identify first-in-class protein degrading molecules with oral potential and high specificity for diseased tissue, ultimately leading to new medicines for patients. If you want to learn more or arrange a meeting with Richard and Simon, you can register to attend here: https://rb.gy/qc7bfg #StartUp #DrugDiscovery #ProteinDegradation #Integrins #Cancer #AutoimmuneDiseases

Introducing our next presenting company at Innovation Showcase, Octiocor! Octiocor's AutoOCT™ web-based platform is a fully automated artificial intelligence neural network-based image analysis system that was developed to identify and measure atherosclerosis from optical coherence tomography (OCT). The software interprets intravascular coronary artery images and will provide real-time decision support for cardiologists and can be used to stratify patients based on risk enabling cardiologists to make better decisions to prevent future heart attacks. To speak with Octiocor's Founder and CMO, Martin Bennett, at this year's Innovation Showcase, you can request a place here: https://rb.gy/qc7bfg #Atherosclerosis #OCT #Cardiology #AI #StartUp

Kicking off our Innovation Showcase series, we have Awen Oncology.   Focused on developing a breakthrough range of anti-cancer drugs, the Company's innovative platform homes in on previously untargeted human developmental genes that, while dormant in healthy tissues, behave unexpectedly in the early stages and progression of cancer.   Awen Oncology was spun out of Bangor University and Cardiff University and recently closed its first major funding round, bringing its total funds raised to over £1 million. You can read more about its investment here: https://rb.gy/7qk0rb   If you're interested in connecting with Dr. Ramsay McFarlane, CEO of Awen Oncology, you can register your interest to attend the Innovation Showcase here: https://rb.gy/qc7bfg   #Oncology #Innovation #StartUp #Investors

📣 Innovation Showcase 2024 is less than a month away! This year four of our portfolio companies will presenting, featuring an update on their company's progress: ⭕Awen Oncology ⭕Emm ⭕Indegra Therapeutics ⭕Octiocor They'll be joined by Cardiac-Tech Ltd, Proxximos, Verinnogen and Adora Digital Health, who will be exhibiting their technology with live demonstrations at this year's showcase. Over the next few weeks we'll be introducing each of our portfolio companies and their unique stories and innovative technologies. 📅Wednesday 13 November 📍Babraham Research Campus If you’re an investor, potential partner or part of the wider #biotech, #healthtech and #lifesciences ecosystem and would like to join us for the Innovation Showcase, please register your interest here: https://rb.gy/qc7bfg #Innovation #Startups #Investors #Cambridge

Today is #WorldMenopauseDay, a day to raise awareness of the menopause and the support systems available to women. The services offered by our portfolio company, Adora Digital Health, provide companies with the tools to support their female employees in the workplace and transform their menopause experience. Adora is led by an expert team of women's health gynaecologists, nutritionists and menopause specialists, and aims to help organisations provide better support for their female workforce using its AI-driven digital health platform. If you'd like the opportunity to speak with the Adora team, they will be exhibiting at our upcoming Innovation Showcase. Register your interest here: https://rb.gy/qc7bfg #Menopause #StartUp #DigitalHealth #Innovation

Our Innovation Showcase is now only four weeks away, so we wanted to take this opportunity to give a shout out to our fantastic sponsors, whose support is invaluable to making the event a success:   Our Gold sponsors: Venner Shipley – Intellectual Property experts and long-standing partners of Start Codon, who advise us and many of our portfolio companies on all things IP. PEM – an accountancy firm that advises businesses, non-profit organisations, individuals and families on critical areas of business, tax and wealth. Taylor Wessing – a global law firm that works closely with clients to crack complex problems, enabling ideas and aspirations to thrive.   Our Silver sponsors: Partners&. – an award-winning insurance advisory business.   And our key partners, who help make the event happen: Babraham Research Campus – who support early-stage bioscience enterprise. We’re delighted that our Showcase is taking place at their dynamic campus, where research and business come together to enable innovation. PitchWork – who support startups to create compelling content – specialising in designing and building pitch decks and presentations to help secure funding. eloquential – who help clients reach their eloquence potential through communications coaching.   To register your interest, please reach out using the following form: https://rb.gy/qc7bfg   #Innovation #StartUps #Investors #LifeSciences #Event